These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26865163)

  • 1. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
    Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
    J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
    PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.
    Lin R; Lacoste J; Nakhaei P; Sun Q; Yang L; Paz S; Wilkinson P; Julkunen I; Vitour D; Meurs E; Hiscott J
    J Virol; 2006 Jun; 80(12):6072-83. PubMed ID: 16731946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
    Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
    Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
    Horner SM; Park HS; Gale M
    J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
    Li XD; Sun L; Seth RB; Pineda G; Chen ZJ
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF.
    Parera M; Martrus G; Franco S; Clotet B; Martinez MA
    PLoS One; 2012; 7(8):e42481. PubMed ID: 22870331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
    Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
    Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
    Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
    J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
    Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
    J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.
    Zamorano Cuervo N; Osseman Q; Grandvaux N
    Viruses; 2018 Jan; 10(2):. PubMed ID: 29385716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.
    Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J
    Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus.
    Horner SM; Liu HM; Park HS; Briley J; Gale M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14590-5. PubMed ID: 21844353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.